Nanosonics (ASX:NAN) logged AU$0.0577 in EPS for 2026, compared with AU$0.0669 a year ago, a Tuesday filing showed.
For the 12 months ended June 30, revenue was AU$203.9 million versus AU$198.6 million previously, the Australia-listed healthcare company added.
The company expects 2027 revenue in the range of AU$220 million to AU$228 million.